Four drugs recommended for approval by CHMP at April meeting
A total of 29 drugs have been recommended for approval in the EU so far in 2022, after four drugs were added to the mix during this month’s meeting of the CHMP, the EMA’s expert committee.
by MIKKEL AABENHUS HEMMINGSEN, translated by daniel pedersen
At its meeting in April, the European Medicines Agency’s (EMA) expert committee, the CHMP, has given a positive opinion on four drugs for European use, and has recommended extensions to the indications of an additional seven medicines.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
CHMP approves 5 new drugs in March
For subscribers
